Published in J Clin Invest on April 01, 1988
Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. J Clin Invest (1989) 0.96
Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest (1989) 0.91
Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. J Clin Invest (1991) 0.85
Neural control of the endocrine rat heart. Proc Natl Acad Sci U S A (1993) 0.78
Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway. J Clin Invest (1994) 0.77
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science (1983) 2.53
The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun (1983) 2.00
Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science (1984) 1.85
Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med (1986) 1.71
Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem Biophys Res Commun (1984) 1.57
Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science (1985) 1.52
Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science (1985) 1.48
Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem Biophys Res Commun (1987) 1.00
The renal response to acute hypervolemia is caused by atrial natriuretic peptides. J Cardiovasc Pharmacol (1986) 0.98
Purification and complete amino acid sequence of beta-rat atrial natriuretic polypeptide (beta-rANP) of 5,000 daltons. Biochem Biophys Res Commun (1984) 0.96
The tissue effects of mineralocorticoids. Am J Med (1972) 0.94
The biochemistry and molecular biology of atrial natriuretic factor. Biochem J (1985) 0.94
Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive rats. Biochem Biophys Res Commun (1985) 0.91
Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem Biophys Res Commun (1985) 0.90
Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. J Clin Invest (1986) 0.90
Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res (1986) 0.90
Chronic infusion of low doses of atrial natriuretic factor (ANF Arg 101-Tyr 126) reduces blood pressure in conscious SHR without apparent changes in sodium excretion. Proc Soc Exp Biol Med (1985) 0.89
Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells. FEBS Lett (1986) 0.82
Antisera to atrial natriuretic factor reduces urinary sodium excretion and increases plasma renin activity in rats. Biochem Biophys Res Commun (1985) 0.81
Monoclonal antibodies to human interferon-gamma. I. Antibodies to a synthetic carboxyl-terminal peptide. J Immunol Methods (1985) 0.81
Atrial natriuretic factor: a new hormone of cardiac origin. Recent Prog Horm Res (1986) 0.80
Arachidonic acid metabolism. Annu Rev Biochem (1986) 6.56
Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A (1993) 3.93
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem (1990) 3.34
Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem (1988) 3.06
Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature (1976) 2.83
Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest (1990) 2.66
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci U S A (1992) 2.55
Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science (1983) 2.53
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
Thromboxanes: selective biosynthesis and distinct biological properties. Science (1976) 2.46
Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol (1995) 2.21
A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer (2007) 2.07
Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A (1979) 2.07
Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther (1973) 2.04
Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs. Circ Res (1974) 1.97
Atriopeptins as cardiac hormones. Hypertension (1985) 1.91
Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science (1984) 1.85
Surgical treatment of an aneurysm in the right aortic arch with aberrant left subclavian artery. Ann Thorac Surg (2001) 1.81
Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J Immunol (1985) 1.76
Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med (1986) 1.71
Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A (1989) 1.67
Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther (1972) 1.67
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest (1977) 1.63
Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem (1988) 1.61
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest (1994) 1.59
Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther (1973) 1.57
Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc Natl Acad Sci U S A (1977) 1.56
Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition. Prostaglandins (1976) 1.56
Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. Prostaglandins (1976) 1.52
Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science (1985) 1.52
Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension (1987) 1.49
Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues. J Clin Invest (1978) 1.48
Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science (1985) 1.48
Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney. Nature (1977) 1.48
Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science (1977) 1.47
Arterio-venous extracorporeal membrane oxygenation of fetal goat incubated in artificial amniotic fluid (artificial placenta): influence on lung growth and maturation. J Pediatr Surg (1998) 1.45
Platelet and blood vessel arachidonate metabolism and interactions. J Clin Invest (1979) 1.44
Specific regulation of peptide-induced renal prostaglandin synthesis. J Biol Chem (1979) 1.43
Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J Clin Invest (1977) 1.42
Anisotropy and corotation of galactic cosmic rays. Science (2006) 1.39
Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol (1995) 1.37
Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator. J Biol Chem (1977) 1.37
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest (1995) 1.33
Mechanism of enhanced fibroblast arachidonic acid metabolism by mononuclear cell factor. J Clin Invest (1984) 1.33
Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest (1986) 1.31
Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins (1977) 1.30
Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ Res (1975) 1.30
Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys. J Pharmacol Exp Ther (1981) 1.30
Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science (1985) 1.29
Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency. J Biol Chem (1985) 1.27
Calcium-dependent norepinephrine release from presynaptic nerve endings in vitro. Proc Natl Acad Sci U S A (1972) 1.27
Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells. J Clin Invest (1983) 1.26
Regional localization of prostacyclin and thromboxane synthesis in dog stomach and intestinal tract. J Pharmacol Exp Ther (1979) 1.26
Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins. Am J Physiol (1977) 1.25
Selective incorporation of 14C-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to 14C-prostaglandins. Prostaglandins (1976) 1.24
Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J Pharmacol Exp Ther (1998) 1.24
Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochem J (1979) 1.23
Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest (1985) 1.22
The biotransformation of nitroglycerin. Biochem Pharmacol (1965) 1.22
The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum (2001) 1.20
Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest (1996) 1.20
Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. Biochemistry (1988) 1.19
Calcium ionophore enables soluble agonists to stimulate macrophage 5-lipoxygenase. J Biol Chem (1985) 1.19
A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart. Proc Natl Acad Sci U S A (1977) 1.15
Mechanism and modification of bradykinin-induced coronary vasodilation. Proc Natl Acad Sci U S A (1975) 1.15
Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit. J Pharmacol Exp Ther (1978) 1.15
Tolerance to the vascular effects of glyceryl trinitrate. J Pharmacol Exp Ther (1970) 1.13
Prostaglandin release by the isolated perfused rabbit heart. Prostaglandins (1973) 1.13
Hormonal stimulation of arachidonate release from isolated perfused organs. Relationship to prostaglandin biosynthesis. Prostaglandins (1977) 1.13
In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharmacol Exp Ther (1994) 1.12
Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction. Biochim Biophys Acta (1977) 1.11
Organic nitrate metabolism. Annu Rev Pharmacol Toxicol (1976) 1.09
The transformation of glyceryl trinitrate and other nitrates by glutathione-organic nitrate reductase. Mol Pharmacol (1965) 1.09
The functional significance of the regulation of macrophage Ia expression by endogenous arachidonate metabolites in vitro. J Immunol (1986) 1.08
Atriopeptins: a family of potent biologically active peptides derived from mammalian atria. Biochem Biophys Res Commun (1984) 1.07
Metabolic and functional alterations in macrophages induced by essential fatty acid deficiency. J Biol Chem (1987) 1.07
Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation. J Clin Invest (1990) 1.07
Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health (2006) 1.06
Thromboxane synthase is preferentially conserved in activated mouse peritoneal macrophages. J Clin Invest (1985) 1.06
Release of renal prostaglandin by catecholamines: relationship to renal endocrine function. J Pharmacol Exp Ther (1974) 1.05
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol (1992) 1.05
Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (2001) 1.04
The synthesis and function of prostaglandins in the heart. Fed Proc (1976) 1.04
Renal concentrations of prostaglandin E in acute and chronic renal ischemia. Biochem Biophys Res Commun (1972) 1.04
Developmental changes in the rat atriopeptin hormonal system. J Clin Invest (1987) 1.03
Specific stimulation and inhibition of renal prostaglandin release by angiotensin analogs. Am J Physiol (1973) 1.02
Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances. Proc Natl Acad Sci U S A (1979) 1.02
Evidence for Pb-O covalency in tetragonal PbTiO3. Phys Rev Lett (2001) 1.02
Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol (1986) 1.01
A novel prostaglandin 11-keto reductase found in rabbit liver. Biochim Biophys Acta (1981) 1.01
Indomethacin in vivo increases the sensitivity to Listeria infection in mice. A possible role for macrophage thromboxane A2 synthesis. J Clin Invest (1987) 1.01
The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol (1989) 1.00
Distribution of glucose and related metabolites in rat kidney. Am J Physiol (1968) 1.00
Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem Biophys Res Commun (1987) 1.00
An atrial peptide is a potent renal vasodilator substance. Circ Res (1984) 1.00
Effects of organic nitrates on mitochondrial respiration and swelling: possible correlations with the mechanism of pharmacologic action. Mol Pharmacol (1966) 0.98
Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci U S A (1990) 0.98
Profile of circulating vasoactive substances in hemorrhagic shock and their pharmacologic manipulation. J Clin Invest (1974) 0.98
Proteolytic processing of atriopeptin prohormone. Mol Pharmacol (1986) 0.97